Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   Fixed Capital/Sales(x) 0.300.450.450.440.47

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.30 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.30
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.3
-33.33
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,420.3 Cr -2.1% -6.2% -28% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,068.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,847.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,985.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,826.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,418.0 Cr 1.5% 6.4% 4.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.1%

-6.2%

-28%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses